ORKA
Oruka Therapeutics, Inc.Company with tickers: ORKA
CIK
907654
CUSIP
687604108
Shares Outstanding
60,312,101
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $25,086,000 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $19,925,000 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-25,086,000 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-20,999,000 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |